{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T02:39:19Z","timestamp":1793414359287,"version":"4.5.0"},"reference-count":37,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["international-journal-of-gynecological-cancer.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Gynecological Cancer"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1136\/ijgc-2024-005359","type":"journal-article","created":{"date-parts":[[2024,11,20]],"date-time":"2024-11-20T01:25:32Z","timestamp":1732065932000},"page":"1853-1860","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["The prognostic value of tumor-infiltrating lymphocytes in vulvovaginal melanoma"],"prefix":"10.1016","volume":"34","author":[{"ORCID":"https:\/\/orcid.org\/0009-0000-3593-4928","authenticated-orcid":false,"given":"Margaux","family":"Vanbockstael","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guillaume","family":"Bataillon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mathilde","family":"Morisseau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8545-4700","authenticated-orcid":false,"given":"Gwenael","family":"Ferron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Justine","family":"Attal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Meresse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emilie","family":"Tournier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yann","family":"Tanguy Le Gac","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C\u00e9cile","family":"Pages","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7633-3536","authenticated-orcid":false,"given":"Alejandra","family":"Martinez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1136\/ijgc-2024-005359_bb0010","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.ygyno.2018.04.562","article-title":"Melanoma of the lower genital tract: Prognostic factors and treatment modalities","volume":"150","author":"Gadducci","year":"2018","journal-title":"Gynecol Oncol"},{"key":"10.1136\/ijgc-2024-005359_bb0015","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1007\/s40257-021-00614-7","article-title":"Vulvar Melanoma: Molecular Characteristics, Diagnosis, Surgical Management, and Medical Treatment","volume":"22","author":"Wohlmuth","year":"2021","journal-title":"Am J Clin Dermatol"},{"key":"10.1136\/ijgc-2024-005359_bb0020","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.semcancer.2019.09.013","article-title":"The mutational landscape of mucosal melanoma","volume":"61","author":"Nassar","year":"2020","journal-title":"Semin Cancer Biol"},{"key":"10.1136\/ijgc-2024-005359_bb0025","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1002\/(SICI)1097-0142(19960401)77:7<1303::AID-CNCR12>3.0.CO;2-5","article-title":"Prognostic value of tumor infiltrating lymphocytes in the vertical growth phase of primary cutaneous melanoma","volume":"77","author":"Clemente","year":"1996","journal-title":"Cancer"},{"key":"10.1136\/ijgc-2024-005359_bb0030","doi-asserted-by":"crossref","first-page":"2678","DOI":"10.1200\/JCO.2011.37.8539","article-title":"Tumor-Infiltrating Lymphocyte Grade Is an Independent Predictor of Sentinel Lymph Node Status and Survival in Patients With Cutaneous Melanoma","volume":"30","author":"Azimi","year":"2012","journal-title":"J Clin Oncol"},{"key":"10.1136\/ijgc-2024-005359_bb0035","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/j.ygyno.2016.04.021","article-title":"Rare vulvar malignancies; incidence, treatment and survival in the Netherlands","volume":"142","author":"Pleunis","year":"2016","journal-title":"Gynecol Oncol"},{"key":"10.1136\/ijgc-2024-005359_bb0040","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1097\/CMR.0b013e32835e590e","article-title":"A large retrospective multicenter study of vaginal melanomas: implications for new management","volume":"23","author":"Vaysse","year":"2013","journal-title":"Melanoma Res"},{"key":"10.1136\/ijgc-2024-005359_bb0045","doi-asserted-by":"crossref","first-page":"6958","DOI":"10.1158\/1078-0432.CCR-11-1595","article-title":"Ipilimumab: An Anti-CTLA-4 Antibody for Metastatic Melanoma","volume":"17","author":"Lipson","year":"2011","journal-title":"Clin Cancer Res"},{"key":"10.1136\/ijgc-2024-005359_bb0050","doi-asserted-by":"crossref","first-page":"5666","DOI":"10.1158\/1078-0432.CCR-16-0663","article-title":"FDA Approval Summary: Accelerated Approval of Pembrolizumab for Second-Line Treatment of Metastatic Melanoma","volume":"23","author":"Chuk","year":"2017","journal-title":"Clin Cancer Res"},{"key":"10.1136\/ijgc-2024-005359_bb0055","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.680407","article-title":"Immunotherapy in Acral and Mucosal Melanoma: Current Status and Future Directions","volume":"12","author":"Mao","year":"2021","journal-title":"Front Immunol"},{"key":"10.1136\/ijgc-2024-005359_bb0060","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1007\/s11912-012-0257-5","article-title":"Tumor-infiltrating lymphocytes in melanoma","volume":"14","author":"Lee","year":"2012","journal-title":"Curr Oncol Rep"},{"key":"10.1136\/ijgc-2024-005359_bb0065","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1136\/ijgc-2023-004696","article-title":"Role of immunotherapy for lymph node positive vulvar melanoma: utilization and outcomes","volume":"33","author":"Nasioudis","year":"2023","journal-title":"Int J Gynecol Cancer"},{"key":"10.1136\/ijgc-2024-005359_bb0070","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.02105","article-title":"Tumor-Infiltrating Lymphocytes and Their Prognostic Value in Cutaneous Melanoma","volume":"11","author":"Maibach","year":"2020","journal-title":"Front Immunol"},{"key":"10.1136\/ijgc-2024-005359_bb0075","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2019.1593806","article-title":"Prognostic value of tumor-infiltrating lymphocytes in melanoma: a systematic review and meta-analysis","volume":"8","author":"Fu","year":"2019","journal-title":"Oncoimmunology"},{"key":"10.1136\/ijgc-2024-005359_bb0080","article-title":"Focus on TILs: prognostic significance of tumor infiltrating lymphocytes in human melanoma","volume":"9","author":"Oble","year":"2009","journal-title":"Cancer Immun"},{"key":"10.1136\/ijgc-2024-005359_bb0085","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1038\/s41379-020-0633-x","article-title":"Distribution pattern of tumor infiltrating lymphocytes and tumor microenvironment composition as prognostic indicators in anorectal malignant melanoma","volume":"34","author":"Kim","year":"2021","journal-title":"Mod Pathol"},{"key":"10.1136\/ijgc-2024-005359_bb0090","doi-asserted-by":"crossref","first-page":"S71","DOI":"10.1038\/modpathol.3800517","article-title":"Prognosticators of melanoma, the melanoma report, and the sentinel lymph node","volume":"19","author":"Crowson","year":"2006","journal-title":"Mod Pathol"},{"key":"10.1136\/ijgc-2024-005359_bb0095","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1093\/annonc\/mdu450","article-title":"The evaluation of tumor-infiltrating lymphocytes (TILs) in breast cancer: recommendations by an International TILs Working Group 2014","volume":"26","author":"Salgado","year":"2015","journal-title":"Ann Oncol"},{"key":"10.1136\/ijgc-2024-005359_bb0100","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1080\/15384047.2015.1040960","article-title":"Tumor infiltrating lymphocytes in ovarian cancer","volume":"16","author":"Santoiemma","year":"2015","journal-title":"Cancer Biol Ther"},{"key":"10.1136\/ijgc-2024-005359_bb0105","doi-asserted-by":"crossref","DOI":"10.1177\/1010428317695023","article-title":"Tumor-infiltrating lymphocytes and breast cancer: Beyond the prognostic and predictive utility","volume":"39","author":"Ravelli","year":"2017","journal-title":"Tumour Biol"},{"key":"10.1136\/ijgc-2024-005359_bb0110","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1159\/000505152","article-title":"Prognostic Significance of Tumor-Infiltrating Lymphocyte Grade in Melanoma: A Meta-Analysis","volume":"236","author":"Sun","year":"2020","journal-title":"Dermatology (Basel)"},{"key":"10.1136\/ijgc-2024-005359_bb0115","doi-asserted-by":"crossref","first-page":"100878","DOI":"10.1016\/j.currproblcancer.2022.100878","article-title":"Characteristics of tumor infiltrating lymphocytes in sinonasal mucosal melanoma and prognosis for patients","volume":"46","author":"Yin","year":"2022","journal-title":"Curr Probl Cancer"},{"key":"10.1136\/ijgc-2024-005359_bb0120","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1002\/lary.29820","article-title":"Prognostic Value of Tumor-Infiltrating Lymphocytes in Sinonasal Mucosal Melanoma","volume":"132","author":"Ledderose","year":"2022","journal-title":"Laryngoscope"},{"key":"10.1136\/ijgc-2024-005359_bb0125","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1001\/jamaoncol.2015.0493","article-title":"Association Between NRAS and BRAF Mutational Status and Melanoma-Specific Survival Among Patients With Higher-Risk Primary Melanoma","volume":"1","author":"Thomas","year":"2015","journal-title":"JAMA Oncol"},{"key":"10.1136\/ijgc-2024-005359_bb0130","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.ygyno.2021.01.018","article-title":"Evaluation of treatment, prognostic factors, and survival in 198 vulvar melanoma patients: Implications for clinical practice","volume":"161","author":"Boer","year":"2021","journal-title":"Gynecol Oncol"},{"key":"10.1136\/ijgc-2024-005359_bb0135","first-page":"1257","article-title":"Vulvar malignancies: an interdisciplinary perspective","volume":"17","author":"Wohlmuth","year":"2019","journal-title":"J Deutsche Derma Gesell"},{"key":"10.1136\/ijgc-2024-005359_bb0140","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.humpath.2022.11.002","article-title":"Different clinico-pathological and prognostic features of vulvar, vaginal, and cervical melanomas","volume":"131","author":"Wu","year":"2023","journal-title":"Hum Pathol"},{"key":"10.1136\/ijgc-2024-005359_bb0145","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/S1028-4559(09)60281-3","article-title":"Primary malignant melanoma of the female genital tract","volume":"48","author":"Gungor","year":"2009","journal-title":"Taiwan J Obstet Gynecol"},{"key":"10.1136\/ijgc-2024-005359_bb0150","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1097\/01.AOG.0000271209.67461.91","article-title":"Vulvar melanoma: a multivariable analysis of 644 patients","volume":"110","author":"Sugiyama","year":"2007","journal-title":"Obstet Gynecol"},{"key":"10.1136\/ijgc-2024-005359_bb0155","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1016\/j.jaad.2014.08.019","article-title":"Vulvar nevi, melanosis, and melanoma: an epidemiologic, clinical, and histopathologic review","volume":"71","author":"Murzaku","year":"2014","journal-title":"J Am Acad Dermatol"},{"key":"10.1136\/ijgc-2024-005359_bb0160","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1097\/PAP.0000000000000161","article-title":"Assessing tumor infiltrating lymphocytes in solid tumors: a practical review for pathologists and proposal for a standardized method from the International Immuno-Oncology Biomarkers Working Group","volume":"24","author":"Hendry","year":"2017","journal-title":"Adv Anat Pathol"},{"key":"10.1136\/ijgc-2024-005359_bb0165","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2022.104143","article-title":"Objective assessment of tumor infiltrating lymphocytes as a prognostic marker in melanoma using machine learning algorithms","volume":"82","author":"Aung","year":"2022","journal-title":"EBioMedicine"},{"key":"10.1136\/ijgc-2024-005359_bb0170","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1038\/s41523-020-0154-2","article-title":"Report on computational assessment of Tumor Infiltrating Lymphocytes from the International Immuno-Oncology Biomarker Working Group","volume":"6","author":"Amgad","year":"2020","journal-title":"NPJ Breast Cancer"},{"key":"10.1136\/ijgc-2024-005359_bb0175","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.humpath.2016.07.008","article-title":"Immunologic heterogeneity of tumor-infiltrating lymphocyte composition in primary melanoma","volume":"57","author":"Weiss","year":"2016","journal-title":"Hum Pathol"},{"key":"10.1136\/ijgc-2024-005359_bb0180","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1158\/2326-6066.CIR-19-0835","article-title":"Tumor Mutation Burden and Structural Chromosomal Aberrations Are Not Associated with T-cell Density or Patient Survival in Acral, Mucosal, and Cutaneous Melanomas","volume":"8","author":"Edwards","year":"2020","journal-title":"Cancer Immunol Res"},{"key":"10.1136\/ijgc-2024-005359_bb0185","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1007\/s00262-019-02378-w","article-title":"Morphomolecular analysis of the immune tumor microenvironment in human head and neck cancer","volume":"68","author":"Badr","year":"2019","journal-title":"Cancer Immunol Immunother"},{"key":"10.1136\/ijgc-2024-005359_bb0190","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/S1470-2045(17)30904-X","article-title":"Tumour-infiltrating lymphocytes and prognosis in different subtypes of breast cancer: a pooled analysis of 3771 patients treated with neoadjuvant therapy","volume":"19","author":"Denkert","year":"2018","journal-title":"Lancet Oncol"}],"container-title":["International Journal of Gynecological Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1048891X24221757?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1048891X24221757?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/ijgc-2024-005359","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T01:09:15Z","timestamp":1764551355000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1048891X24221757"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":37,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2024,12]]}},"alternative-id":["S1048891X24221757"],"URL":"https:\/\/doi.org\/10.1136\/ijgc-2024-005359","relation":{},"ISSN":["1048-891X"],"issn-type":[{"value":"1048-891X","type":"print"}],"subject":[],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The prognostic value of tumor-infiltrating lymphocytes in vulvovaginal melanoma","name":"articletitle","label":"Article Title"},{"value":"International Journal of Gynecological Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1136\/ijgc-2024-005359","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2024 IGCS and ESGO 2024. No commercial re-use. See rights and permissions. Published by BMJ.","name":"copyright","label":"Copyright"}]}}